Further quantification of the tumor-specific density of this subset of cells in Ndst1f/f CD11cCre+ mutant versus Cre- control tumor-bearing mice revealed a significantly lower CD163+ cell density in mutant tumors (Fig. 3A). The gene discussed is CD163; the disease is neoplasm.